Skip to main content
# Title Department Research Year
111 New Cell Cycle Checkpoint Pathways Regulators with 2-Oxo-indoline Scaffold as Potential Anticancer Agents: Design, Synthesis, Biological Activities and In Silico Studies Department of Medicinal Chemistry 2022
112 Design, synthesis, crystal structures and biological evaluation of some 1, 3-thiazolidin-4-ones as dual CDK2/EGFR potent inhibitors with potential apoptotic antiproliferative effects 2022
113 New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization Department of Pharmaceutical Organic Chemistry 2022
114 Selective Cytotoxic Constituents from Gardenia latifolia and Their In Silico Topoisomerase IIα Inhibition Department of Pharmacognosy 2022
115 Biomedical applications of quantum dots: overview, challenges and clinical potentials Department of Industrial Pharmacy 2022
116 Antibacterial and wound-healing potential of PLGA/spidroin nanoparticles: a study on earthworms as a human skin model 2022
117 A Comprehensive Review on Analytical Techniques for Determination of Sex Stimulants, PDE5 Inhibitors in Different Matrices with Special Focus on the Electroanalytical Methods Department of Pharmaceutical Analytical Chemistry 2022
118 Design and optimization of metformin hydrophobic ion pairs for efcient encapsulation in polymeric drug carriers Department of Pharmaceutics 2022
119 Optimization and SAR investigation of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as EGFR and BRAFV600E dual inhibitors with potent antiproliferative and antioxidant activities Department of Pharmaceutical Organic Chemistry 2022
120 Synthesis and Biological Evaluation of Indole-2-Carboxamides with Potent Apoptotic Antiproliferative Activity as EGFR/CDK2 Dual Inhibitors 2022